- #893 Ajay Kumar Tyagi & family ₹3,300 Cr

Sanskar Medica India Limited
About Sanskar Medica India Limited
Data last updated:
Sanskar Medica India Limited is a public limited company based in Centre, Delhi, India, a subsidiary of Yatharth Hospital & Trauma Care Services Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 2016 and has been in existence for over 10 years.
Its director Ajay Kumar Tyagi and family are #893 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2016PLC301083.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.62 Cr. It was formerly known as Yatharth Hospital Private Limited and Sanskar Medica India Private Limited. It is led by directors including Neena Tyagi and Ajay Kumar Tyagi.
Its last annual general meeting (AGM) was held on 18 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ja 108 DLF Tower A, Centre, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.1 Lakh. For the same year it recorded a net profit of ₹30.7 Lakh (net margin 82.7%) and EBITDA of ₹36.7 Lakh (EBITDA margin 98.9%).
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Sanskar Medica India has undergone 2 name changes throughout its history. The company was previously known as Yatharth Hospital Private Limited, and Sanskar Medica India Private Limited. The current legal name is Sanskar Medica India Limited.
| Company Name | Status |
|---|---|
| Sanskar Medica India Limited | Current |
| Yatharth Hospital Private Limited | Previous |
| Sanskar Medica India Private Limited | Previous |
CIN history
Sanskar Medica India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100DL2016PLC301083, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100DL2016PLC301083 | Current |
| U24100DL2016PTC301083 | Previous |
| U85110DL2016PTC301083 | Previous |
Recognitions & Rankings of Sanskar Medica India
Contact details
Sanskar Medica India Limited's registered office is in Centre, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressJa 108 DLF Tower A, Centre, Delhi, India – 110025
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanskar Medica India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sanskar Medica India Limited
FY 2024 filings availableSanskar Medica India Limited reported revenue of ₹37.1 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98.9% | ||||
| Net Profit Margin | 82.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanskar Medica India Limited, buy the company report.
Board of directors of Sanskar Medica India Limited
Sanskar Medica India has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neena Tyagi Also directs: Aks Medical & Research Centre Private Limited | Director | 26 Mar 2018 | 8 Years 7 Months | Current |
| Ajay Kumar Tyagi Also directs: Aks Medical & Research Centre Private Limited, Tony's Gourmet Products LLP, Happy Valley Infra LLP and 5 more | Director | 08 Jun 2016 | 10 Years 4 Months | Current |
| Manju Tyagi | Director | 26 Mar 2018 | 8 Years 7 Months | Current |
| Kapil Kumar | Director | 08 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Sanskar Medica India Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SV Biotech Private Limited | ₹37.4 Lakh (FY 2025) | -21.0% | Pune, Maharashtra, India | |||
| Sanicor Life Science Private Limited | ₹37.35 Lakh (FY 2025) | 2.0% | Kanpur, Uttar Pradesh, India | |||
| Sabwell Pharmaceuticals Private Limited | ₹37.27 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Bestia Formulations Private Limited | ₹37.13 Lakh (FY 2025) | 39.0% | Ambala, Haryana, India | |||
| Abrahams Homoeopathy Private Limited | ₹37.13 Lakh (FY 2025) | 9.0% | Pudukkottai, Tamil Nadu, India | |||
| Sanskar Medica India Limitedthis company | ₹37.1 Lakh (FY 2025) | ₹30.7 Lakh | 82.7% | Centre, Delhi, India | ||
| Menald Pharmaceuticals Private Limited | ₹36.98 Lakh (FY 2022) | -63.0% | New Delhi, Delhi, India | |||
| Devrekha Pharmaceuticals Private Limited | ₹36.8 Lakh (FY 2025) | 191.0% | Gangoh, Uttar Pradesh, India | |||
| Garnichem Pharma Private Limited | ₹36.64 Lakh (FY 2025) | 31.0% | Vasai, Maharashtra, India | |||
| Bajaj Health and Nutritions Private Limited | ₹36.64 Lakh (FY 2024) | 204.0% | Mumbai, Maharashtra, India | |||
| Jiyo Ayurveda Private Limited | ₹36.62 Lakh (FY 2025) | 155.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sanskar Medica India Limited, buy the company report.
Auditor
Sanskar Medica India Limited is audited by MAPSS AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAPSS AND COMPANY | FY 2023 | 0012796C |
Shareholding
The shareholding of Sanskar Medica India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanskar Medica India Limited, buy the company report.
Legal cases
Sanskar Medica India Limited has 1 court case on record: 1 filed by Sanskar Medica India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, New Delhi Bench Court-III | Company petition | Filed by the company | Disposed |
To see the full case history of Sanskar Medica India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanskar Medica India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanskar Medica India Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanskar Medica India Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Manju Tyagi ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Sanskar Medica India is an active public limited company based in Centre, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 2016 (10+ years old) and is registered under CIN U24100DL2016PLC301083.
Sanskar Medica India has 4 current directors:
- Neena Tyagi - Director
- Ajay Kumar Tyagi - Director
- Manju Tyagi - Director
- Kapil Kumar - Director
The latest financial statements of Sanskar Medica India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 18 September 2024. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Sanskar Medica India is U24100DL2016PLC301083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanskar Medica India has 1 court case on record: 1 filed by the company.
Sanskar Medica India was incorporated on 08 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sanskar Medica India by revenue are SV Biotech Private Limited, Sanicor Life Science Private Limited, Sabwell Pharmaceuticals Private Limited, Bestia Formulations Private Limited, Abrahams Homoeopathy Private Limited and 5 more, all in the Pharma industry (Formulations).
Manju Tyagi ceased to be Additional Director on 29 Sep 2018. Neena Tyagi ceased to be Additional Director on 29 Sep 2018. Manju Tyagi was appointed as Director on 26 Mar 2018. Sanskar Medica India has 6 board changes on record in total.
The registered office of Sanskar Medica India is at Ja 108 DLF Tower A, Centre, Delhi, India – 110025.
Sanskar Medica India operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sanskar Medica India is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.

